Nomura lowered the target price for Sino Biopharm (01177) to HKD8.67 from HKD9.17 and maintained the "buy" rating.
The research house said it fine-tunes FY26F/FY27F topline by 1.9%/-1.6% and cuts earnings estimates by 2.8%/7.3%.
【你點睇?】日本自衛隊員持刀闖中國大使館,你認為中日關係會否因此事件進一步緊張?► 立即投票

























